Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Cleave Biosciences
866 Malcolm, Suite 100
Burlingame, CA 94010
Phone: 650-443-3000
www.cleavebio.com

Cleave Biosciences is discovering and developing novel small molecule therapies for difficult-to-treat cancers. Cleave has amassed deep expertise and developed first-in-class drug candidates against novel targets in protein degradation pathways, including the ubiquitin proteasome and autophagy systems. Cleave is using molecular profiling approaches with the goal of identifying patient subsets most likely to benefit from each of its targeted drugs. Cleave is privately held and located in Burlingame, California.

Key Contact
Name
Laura Shawver
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
04/09/13 $10,000,000 Series A
08/08/16 $37,000,000 Series B 5AM Ventures
Arcus Ventures
Astellas Venture Management
Celgene Corporation
Clarus Ventures
Nextech Invest
OrbiMed Advisors
Osage University Partners
US Venture Partners
undisclosed